Latest Regulation News

Evolution Energy Minerals has fast-tracked its Chilalo Graphite Project in Tanzania, aiming to begin ore mining by late 2027 amid strong government partnership and advancing financing talks.

Actinogen Medical has received approval for an additional $1.87 million research and development tax rebate, bringing its total FY25 rebate to $7.36 million. This funding underpins ongoing clinical trials of its Alzheimer’s and depression therapy candidate, Xanamem.

BMG Resources has addressed recent unusual trading activity, confirming no undisclosed material information and providing an update on its Bullabulling drilling program results.

Red Sky Energy has mobilised drilling equipment to the KN2 well site at Killanoola, with regulatory approvals advancing smoothly and drilling expected to begin soon.

Algorae Pharmaceuticals has signed a binding term sheet with India’s Cadila Pharmaceuticals to introduce two generic medicines targeting cardiovascular and metabolic disorders in Australia and New Zealand.

Race Oncology showcased compelling preclinical data at ESMO 2025 revealing that their drug RC220, combined with doxorubicin, not only shields the heart from toxicity but also boosts anticancer effects, supporting ongoing clinical trials.

GreenX Metals has uncovered a significant 1940 historical copper estimate of 728,000 tonnes at 2.6% grade from its Tannenberg Project in Germany, validated by a 1984 drilling campaign including silver by-product. The discovery supports a modern exploration model and sets the stage for a new drilling program to confirm and upgrade the resource.

Brazilian Critical Minerals has achieved a major environmental milestone at its Ema Rare Earth Elements project, successfully restoring clay chemistry post in-situ recovery trials. This breakthrough supports regulatory approvals and moves the project closer to production.

Ardea Resources has extended its Major Project Status for the Kalgoorlie Nickel Project, reinforcing its strategic role in Australia's critical minerals sector and ensuring continued government support.

DGL Group Limited remains suspended from ASX trading following delays in lodging audited accounts and a concerning auditor disclaimer. Investors await clarity on the company’s financial health and path to reinstatement.

BlackRock Investment Management (Australia) Limited has announced final cash distributions for its iShares Balanced ESG ETF and High Growth ESG ETF, detailing payment schedules and reinvestment options for investors.

PainChek Limited has appointed Sasha Grant as Head of Growth for its AI-powered Infant App, aiming to scale its presence in a $15 billion global market. Early Australian adoption shows promising conversion rates as the company prepares for international expansion.